## Serial Radiographic Assessment in CTEV During Conservative Treatment ### Clinical Scenario After 8 weeks of Ponseti casting, radiographic re-assessment is needed to: - Measure improvement in talocalcaneal angle (TCA) and talonavicular angle - Determine if the deformity is correcting adequately - Guide decision to continue casting, add percutaneous tenotomy, or proceed to surgery ### Why Plain Radiographs Remain the Standard **Key Point:** Serial plain radiographs (AP and lateral) are the standard for monitoring response to Ponseti treatment because they directly measure the same angles used for initial severity grading. **High-Yield:** The Dimeglio score and angle measurements are reproducible on plain films: - **Talocalcaneal angle (TCA):** Should improve from <15° toward normal (>25°) - **Talonavicular angle:** Should decrease as adduction corrects - **Tibiocalcaneal angle:** Should increase as equinus corrects ### Comparison of Imaging Modalities at This Stage | Modality | Role in CTEV Monitoring | Timing | |---|---|---| | **Plain radiograph** | Serial angle measurement, treatment response assessment | Every 4–6 weeks during casting | | **3D CT** | Complex anatomy, pre-operative surgical planning | Only if surgery planned | | **MRI** | Soft tissue, associated anomalies, research | Not routine; selected cases | | **Ultrasound** | Early detection, soft tissue; less useful for angle measurement | Prenatal/neonatal; not for follow-up | **Clinical Pearl:** The Ponseti protocol relies on serial radiographs to confirm angle correction. If angles are not improving despite casting, percutaneous Achilles tenotomy or surgical release may be indicated. **Tip:** Do not order advanced imaging (CT, MRI) unless plain films show inadequate correction and surgical planning is imminent. Plain radiographs are sufficient for monitoring and decision-making during conservative therapy. [cite:Campbell's Operative Orthopaedics 13e Ch 31] 
Sign up free to access AI-powered MCQ practice with detailed explanations and adaptive learning.